New members and focus on the CRG Business Board

by Centre for Genomic Regulation

CRG Technology and Business Development Office has redefined its priorities and the way it brings innovative ideas to the market, launching several new programs and activities to promote commercializa...

Read more

'Spark', a new public-private project created to develop a drug to fight the cognitive impairment associated with schizophrenia

by IRB Barcelona - Instituto de Investigación Biomédica

The expected end-result will be the obtaining of an optimal formulation and a route of administration of the compound for its use as a drug in patients. This will allow carrying out the regulatory pre...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Closing in on Myc inhibition: a marathon...

by VHIO

We have come a long way to get to this point, with many twists and une...

Photos Stream